J H Bourhis - JoVE Visualize

Showing results (51-60 of 78) with videos related to

Pageof 8

Sort By:

Leukemia|March 3, 2006

High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)E Jabbour, S Koscielny, C Sebban, et al.

Leukemia & Lymphoma|December 28, 1999

Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphomaA Ulusakarya, J Lumbroso, O Casiraghi, et al.

British Journal of Haematology|November 25, 2003

Adult T-biphenotypic acute leukaemia: clinical and biological features and outcomeM T Rubio, N Dhedin, C Boucheix, et al.

Radiology|August 1, 1997

Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patientsN Lassau, J Leclère, A Auperin, et al.

British Journal of Haematology|July 1, 1997

Should cytomegalovirus be tested for in both blood and bronchoalveolar lavage fluid of patients at a high risk of CMV pneumonia after bone marrow transplantation?A Ibrahim, E Gautier, S Roittmann, et al.

Bone Marrow Transplantation|July 12, 2005

Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trialD Valteau-Couanet, C Faucher, A Aupérin, et al.

Bone Marrow Transplantation|January 10, 2024

Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registryA Sadowska-Klasa, J M Zaucha, M Labopin, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996

Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myelomaG Marit, C Faberes, J L Pico, et al.

Bone Marrow Transplantation|March 20, 2012

Evaluation of allogeneic hematopoietic SCT in younger adults with adverse karyotype AMLM A Hospital, X Thomas, S Castaigne, et al.

Bone Marrow Transplantation|October 19, 2004

Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphomaD Decaudin, J-M Vantelon, J-H Bourhis, et al.

Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:

Pageof 8

Leukemia|March 3, 2006

High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)E Jabbour, S Koscielny, C Sebban, et al.

Leukemia & Lymphoma|December 28, 1999

Gallium scan in the evaluation of post chemotherapy mediastinal residual masses of aggressive non-Hodgkin's lymphomaA Ulusakarya, J Lumbroso, O Casiraghi, et al.

British Journal of Haematology|November 25, 2003

Adult T-biphenotypic acute leukaemia: clinical and biological features and outcomeM T Rubio, N Dhedin, C Boucheix, et al.

Radiology|August 1, 1997

Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patientsN Lassau, J Leclère, A Auperin, et al.

British Journal of Haematology|July 1, 1997

Should cytomegalovirus be tested for in both blood and bronchoalveolar lavage fluid of patients at a high risk of CMV pneumonia after bone marrow transplantation?A Ibrahim, E Gautier, S Roittmann, et al.

Bone Marrow Transplantation|July 12, 2005

Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trialD Valteau-Couanet, C Faucher, A Aupérin, et al.

Bone Marrow Transplantation|January 10, 2024

Allogeneic hematopoietic cell transplantation is equally effective in secondary acute lymphoblastic leukemia (ALL) compared to de-novo ALL-a report from the EBMT registryA Sadowska-Klasa, J M Zaucha, M Labopin, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1996

Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myelomaG Marit, C Faberes, J L Pico, et al.

Bone Marrow Transplantation|March 20, 2012

Evaluation of allogeneic hematopoietic SCT in younger adults with adverse karyotype AMLM A Hospital, X Thomas, S Castaigne, et al.

Bone Marrow Transplantation|October 19, 2004

Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphomaD Decaudin, J-M Vantelon, J-H Bourhis, et al.

Pageof 8